Brant Point Investment Management LLC Sells 18,269 Shares of Phibro Animal Health Corporation $PAHC

Brant Point Investment Management LLC lowered its stake in Phibro Animal Health Corporation (NASDAQ:PAHC) by 17.6% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 85,455 shares of the company’s stock after selling 18,269 shares during the quarter. Brant Point Investment Management LLC owned approximately 0.21% of Phibro Animal Health worth $2,183,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Nuveen LLC acquired a new position in Phibro Animal Health during the 1st quarter worth approximately $10,312,000. Invesco Ltd. boosted its position in Phibro Animal Health by 92.3% in the first quarter. Invesco Ltd. now owns 387,739 shares of the company’s stock valued at $8,282,000 after buying an additional 186,087 shares in the last quarter. Millennium Management LLC grew its stake in shares of Phibro Animal Health by 74.3% during the first quarter. Millennium Management LLC now owns 362,030 shares of the company’s stock worth $7,733,000 after buying an additional 154,281 shares during the last quarter. Russell Investments Group Ltd. increased its holdings in shares of Phibro Animal Health by 711.1% during the first quarter. Russell Investments Group Ltd. now owns 122,600 shares of the company’s stock worth $2,619,000 after buying an additional 107,485 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership increased its holdings in shares of Phibro Animal Health by 43.2% during the second quarter. Arrowstreet Capital Limited Partnership now owns 275,066 shares of the company’s stock worth $7,025,000 after buying an additional 83,018 shares in the last quarter. 99.34% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

PAHC has been the topic of several recent research reports. Weiss Ratings reissued a “buy (b-)” rating on shares of Phibro Animal Health in a report on Monday, December 1st. Zacks Research downgraded Phibro Animal Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 10th. JPMorgan Chase & Co. lifted their price target on Phibro Animal Health from $45.00 to $50.00 and gave the company an “overweight” rating in a research note on Friday, November 7th. Morgan Stanley set a $34.00 price objective on Phibro Animal Health in a research note on Thursday, August 28th. Finally, Bank of America upped their price objective on Phibro Animal Health from $19.00 to $27.00 and gave the company an “underperform” rating in a research note on Friday, August 29th. Two research analysts have rated the stock with a Buy rating, four have given a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $31.40.

Phibro Animal Health Stock Down 3.9%

Shares of PAHC opened at $39.16 on Monday. The stock’s 50-day moving average price is $41.20 and its two-hundred day moving average price is $34.09. Phibro Animal Health Corporation has a 12 month low of $16.16 and a 12 month high of $46.42. The company has a market capitalization of $1.59 billion, a PE ratio of 23.59, a PEG ratio of 1.11 and a beta of 0.77. The company has a current ratio of 3.09, a quick ratio of 1.35 and a debt-to-equity ratio of 2.32.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings results on Wednesday, November 5th. The company reported $0.73 earnings per share for the quarter, beating the consensus estimate of $0.58 by $0.15. The company had revenue of $363.89 million during the quarter, compared to analysts’ expectations of $345.44 million. Phibro Animal Health had a return on equity of 36.26% and a net margin of 4.85%.Phibro Animal Health has set its FY 2026 guidance at 2.640-2.810 EPS. On average, analysts anticipate that Phibro Animal Health Corporation will post 1.95 EPS for the current year.

Phibro Animal Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 17th. Shareholders of record on Wednesday, November 26th will be issued a dividend of $0.12 per share. The ex-dividend date is Wednesday, November 26th. This represents a $0.48 annualized dividend and a yield of 1.2%. Phibro Animal Health’s dividend payout ratio (DPR) is presently 28.92%.

Insider Activity

In other news, CEO Jack Bendheim sold 38,303 shares of the company’s stock in a transaction on Monday, November 10th. The shares were sold at an average price of $45.29, for a total value of $1,734,742.87. Following the sale, the chief executive officer directly owned 20,577 shares of the company’s stock, valued at approximately $931,932.33. This represents a 65.05% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In the last 90 days, insiders have sold 160,616 shares of company stock valued at $6,906,131. 50.13% of the stock is currently owned by insiders.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.